Related references
Note: Only part of the references are listed.Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
Eric Tartour et al.
CANCER AND METASTASIS REVIEWS (2011)
Regulatory dendritic cells New targets for cancer immunotherapy
Michael R. Shurin et al.
CANCER BIOLOGY & THERAPY (2011)
Epidemiologic perspective on immune-surveillance in cancer
Daniel W. Cramer et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Chemokines in cancer related inflammation
Paola Allavena et al.
EXPERIMENTAL CELL RESEARCH (2011)
Infection, immunoregulation, and cancer
Graham A. W. Rook et al.
IMMUNOLOGICAL REVIEWS (2011)
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
Barbara Molon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
Immune parameters affecting the efficacy of chemotherapeutic regimens
Laurence Zitvogel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
Christiane Meyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells
Ramon Kaneno et al.
CELLULAR ONCOLOGY (2011)
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
Suzanne Ostrand-Rosenberg
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Minu K. Srivastava et al.
CANCER RESEARCH (2010)
Immature Immunosuppressive CD14+HLA-DR-/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
Isabel Poschke et al.
CANCER RESEARCH (2010)
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
Julie Vincent et al.
CANCER RESEARCH (2010)
Molecular Pathways Linking Inflammation and Cancer
A. Mantovani
CURRENT MOLECULAR MEDICINE (2010)
Myeloid-derived suppressor cell heterogeneity and subset definition
Elisa Peranzoni et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
Claus Garbe et al.
EUROPEAN JOURNAL OF CANCER (2010)
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
Ilaria Marigo et al.
IMMUNITY (2010)
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Srinivas Nagaraj et al.
JOURNAL OF IMMUNOLOGY (2010)
Anti-CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy
Margaret K. Callahan et al.
SEMINARS IN ONCOLOGY (2010)
New views on natural killer cell-based immunotherapy for melanoma treatment
Shannon Burke et al.
TRENDS IN IMMUNOLOGY (2010)
Epidemiology of invasive cutaneous melanoma
R. M. MacKie et al.
ANNALS OF ONCOLOGY (2009)
Modulators of arginine metabolism support cancer immunosurveillance
Giusy Capuano et al.
BMC IMMUNOLOGY (2009)
Activation of p38 Mitogen-Activated Protein Kinase Drives Dendritic Cells to Become Tolerogenic in Ret Transgenic Mice Spontaneously Developing Melanoma
Fang Zhao et al.
CLINICAL CANCER RESEARCH (2009)
Therapeutic targeting of myeloid-derived suppressor cells
Stefano Ugel et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Skin Melanoma Development in ret Transgenic Mice Despite the Depletion of CD25+Foxp3+ Regulatory T Cells in Lymphoid Organs
Silvia Kimpfler et al.
JOURNAL OF IMMUNOLOGY (2009)
Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism
Galina V. Shurin et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells
Erica M. Hanson et al.
JOURNAL OF IMMUNOLOGY (2009)
Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations
Ramon Kaneno et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Melanoma-Specific Memory T Cells Are Functionally Active in Ret Transgenic Mice without Macroscopic Tumors
Viktor Umansky et al.
CANCER RESEARCH (2008)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
Immune surveillance: a balance between protumor and antitumor immunity
Suzanne Ostrand-Rosenberg
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
The genetics of malignant melanoma
Jesus Lomas et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
STRATEGIES TO OVERCOME OBSTACLES TO SUCCESSFUL IMMUNOTHERAPY OF MELANOMA
F. Pandolfi et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2008)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2008)
Low-dose chemotherapeutic agents regulate small Rho GTPase activity in dendritic cells
Galina V. Shurin et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Ping-Ying Pan et al.
BLOOD (2008)
The RTK/RAS/BRAF/PI3K pathways in melanoma: Biology, small molecule inhibitors, and potential applications
Frank Haluska et al.
SEMINARS IN ONCOLOGY (2007)
Innate Vα14+ natural killer T cells mature dendritic cells, leading to strong adaptive immunity
Shin-Ichiro Fujii et al.
IMMUNOLOGICAL REVIEWS (2007)
Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth
Zhong Hua et al.
CLINICAL CANCER RESEARCH (2007)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
MyD88-dependent expansion of an immature GR-1+ CD11b+ population induces T cell suppression and Th2 polarization in sepsis
Matthew J. Delano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Melanoma immunology: past, present and future
Giorgio Parmiani et al.
CURRENT OPINION IN ONCOLOGY (2007)
Humoral immunity, inflammation and cancer
Ting-Ting Tan et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Combined chemoimmunotherapy of solid tumours: Improving vaccines?
Anna K. Nowak et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
TCR ζ down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs
Analia V. Ezernitchi et al.
JOURNAL OF IMMUNOLOGY (2006)
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
Noweeda Mirza et al.
CANCER RESEARCH (2006)
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
Hossein A. Ghofrani et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells
Hidetoshi Sumimoto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
T cell dysfunction in cancer:: Role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress
PC Rodríguez et al.
SEMINARS IN CANCER BIOLOGY (2006)
Chronic inflammation, immunosuppression and cancer: New insights and outlook
M Baniyash
SEMINARS IN CANCER BIOLOGY (2006)
Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro
S Rössner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity
E Suzuki et al.
CLINICAL CANCER RESEARCH (2005)
Regulation of immune responses by L- arginine metabolism
V Bronte et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination
C De Santo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2
PA Antony et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease
P Sinha et al.
JOURNAL OF IMMUNOLOGY (2005)
Tcr ζ-chain downregulation:: Curtailing an excessive inflammatory immune response
M Baniyash
NATURE REVIEWS IMMUNOLOGY (2004)
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
A Sparmann et al.
CANCER CELL (2004)
Sustained exposure to bacterial antigen induces interferon-γ-dependent T cell receptor down-regulation and impaired T cell function
N Bronstein-Sitton et al.
NATURE IMMUNOLOGY (2003)
Downregulation of tapasin expression in progressive human malignant melanoma
J Dissemond et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2003)
Viagra® (sildenafil citrate) and ophthalmology
AM Laties et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2002)
Regulation of T cell receptor CD3 chain expression by L-arginine
PC Rodriguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
CD3-zeta chain expression of intratumoral lymphocytes is closely related to survival in gastric carcinoma patients
S Ishigami et al.
CANCER (2002)
Autocrine and paracrine regulation by cytokines and growth factors in melanoma
E Lázár-Molnár et al.
CYTOKINE (2000)